Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 08, 2025 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 9F9Y | P10104 | SARS-CoV-2 BA-2.87.1 Spike ectodomain | |
| 9F9Y | P0DTC2 | SARS-CoV-2 BA-2.87.1 Spike ectodomain | |
| 8THF | P0DTC2 | SARS-CoV-2 BA.1 S-6P-no-RBD | |
| 7XJ6 | P0DTC2 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation | |
| 7XJ6 | 7XJ6 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation | |
| 7XJ8 | P0DTC2 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation | |
| 7XJ8 | 7XJ8 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation | |
| 7WWI | P0DTC2 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation | |
| 7WWI | 7WWI | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation | |
| 7WWJ | P0DTC2 | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation | |
| 7WWJ | 7WWJ | SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation | |
| 8ERQ | P0DTC2 | SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324) | |
| 8ERQ | 8ERQ | SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragment (local refinement of the RBD and S2X324) | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | 8H08 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | P0DTC2 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H08 | 8H08 | SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8BH5 | 8BH5 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
| 8BH5 | P0DTC2 | SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody | |
| 7YQT | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | |
| 7YQU | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
| 7YQW | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | |
| 7YR2 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
| 7YR2 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) | |
| 7YR3 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
| 7YR3 | Q9BYF1 | SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) | |
| 7YR0 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
| 7YR0 | 7YR0 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) | |
| 7YQX | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
| 7YQX | 7YQX | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) | |
| 7YQY | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
| 7YQY | 7YQY | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) | |
| 7YQZ | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
| 7YQZ | 7YQZ | SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) | |
| 7YR1 | P0DTC2 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
| 7YR1 | 7YR1 | SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 | |
| 8X5R | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (1 RBD up) | |
| 8X5Q | P0DTC2 | SARS-CoV-2 BA.2.75 Spike with K356T mutation (3 RBD down) | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | P0DTC2 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8H07 | 8H07 | SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C | |
| 8S9G | Q9BYF1 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | P0DTC2 | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S9G | 8S9G | SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8S6M | 8S6M | SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments | |
| 8S6M | P0DTC2 | SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments | |
| 8FXC | Q9BYF1 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | P0DTC2 | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment | |
| 8FXC | 8FXC | SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment |
